BioCardia, Inc. (BCDA)

BioCardia Statistics

Total Valuation

BioCardia has a market cap or net worth of $9.03 million. The enterprise value is $7.61 million.

Market Cap	9.03M
Enterprise Value	7.61M

Important Dates

The next estimated earnings date is Tuesday, May 13, 2025, after market close.

Earnings Date	May 13, 2025
Ex-Dividend Date	n/a

Share Statistics

BioCardia has 4.68 million shares outstanding. The number of shares has increased by 94.32% in one year.

Current Share Class	4.68M
Shares Outstanding	4.68M
Shares Change (YoY)	+94.32%
Shares Change (QoQ)	+62.25%
Owned by Insiders (%)	19.00%
Owned by Institutions (%)	2.78%
Float	3.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	91.30
Forward PS	n/a
PB Ratio	10.61
P/TBV Ratio	10.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	131.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.14.

Current Ratio	1.13
Quick Ratio	1.02
Debt / Equity	1.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-149.03%
Return on Invested Capital (ROIC)	-666.75%
Return on Capital Employed (ROCE)	-570.28%
Revenue Per Employee	$2,900
Profits Per Employee	-$397,300
Employee Count	20
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.24% in the last 52 weeks. The beta is 1.21, so BioCardia's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-67.24%
50-Day Moving Average	2.43
200-Day Moving Average	2.54
Relative Strength Index (RSI)	34.93
Average Volume (20 Days)	97,627

Short Selling Information

The latest short interest is 52,834, so 1.13% of the outstanding shares have been sold short.

Short Interest	52,834
Short Previous Month	49,965
Short % of Shares Out	1.13%
Short % of Float	1.43%
Short Ratio (days to cover)	0.99

Income Statement

In the last 12 months, BioCardia had revenue of $58,000 and -$7.95 million in losses. Loss per share was -$2.90.

Revenue	58,000
Gross Profit	-4.33M
Operating Income	-8.00M
Pretax Income	n/a
Net Income	-7.95M
EBITDA	-7.93M
EBIT	-8.00M
Loss Per Share	-$2.90

Balance Sheet

The company has $2.37 million in cash and $951,000 in debt, giving a net cash position of $1.42 million or $0.30 per share.

Cash & Cash Equivalents	2.37M
Total Debt	951,000
Net Cash	1.42M
Net Cash Per Share	$0.30
Equity (Book Value)	837,000
Book Value Per Share	0.18
Working Capital	301,000

Cash Flow

In the last 12 months, operating cash flow was -$8.03 million and capital expenditures -$6,000, giving a free cash flow of -$8.03 million.

Operating Cash Flow	-8.03M
Capital Expenditures	-6,000
Free Cash Flow	-8.03M
FCF Per Share	-$1.72

Margins

Gross Margin	n/a
Operating Margin	-13,794.83%
Pretax Margin	-13,700.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioCardia does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-94.32%
Shareholder Yield	-94.32%
Earnings Yield	-87.97%
FCF Yield	-88.92%

Analyst Forecast

The average price target for BioCardia is $25.00, which is 1,195.34% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.00
Price Target Difference	1,195.34%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	248.63%
EPS Growth Forecast (5Y)	-22.39%

Stock Splits

The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	May 30, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

BioCardia has an Altman Z-Score of -65.25 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-65.25
Piotroski F-Score	1